Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib.

about

Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib.

Item

http://www.wikidata.org/entity/Q47205983

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@en

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@nl

type

Item

label

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@en

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@nl

prefLabel

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@en

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@nl

P1476

Metformin sensitizes lung canc ...... ne kinase inhibitor erlotinib.

@en

P2093

Beili Gao

http://www.w3.org/2001/XMLSchema#string

Guochao Shi

http://www.w3.org/2001/XMLSchema#string

Jae Hong Kim

http://www.w3.org/2001/XMLSchema#string

Ji Ming Wang

http://www.w3.org/2001/XMLSchema#string

Jiaqiang Huang

http://www.w3.org/2001/XMLSchema#string

Keqiang Chen

http://www.w3.org/2001/XMLSchema#string

Min Zhou

http://www.w3.org/2001/XMLSchema#string

Poonam Tewary

http://www.w3.org/2001/XMLSchema#string

Qingyun Li

http://www.w3.org/2001/XMLSchema#string

Thomas Sayers

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?

Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities

Anti-tumor activity of metformin: from metabolic and epigenetic perspectives

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Cancer statistics, 2016

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

EGFR antagonists in cancer treatment

EGF-ERBB signalling: towards the systems level

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.

P304

109068-109078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22596

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312591

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

5752504

http://www.w3.org/2001/XMLSchema#string